Clinical Trial Results:
Dose Tolerability Study with High Dose PURETHAL Mites in Allergic Rhinitis / Rhinoconjunctivitis Patients.
An open study to assess tolerability, safety and short-term efficacy of high dose PURETHAL Mites in patients with allergic rhinitis / rhinoconjunctivits induced by house dust mites.
Summary
|
|
EudraCT number |
2008-006261-81 |
Trial protocol |
DE |
Global completion date |
24 Aug 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Jan 2017
|
First version publication date |
25 Jan 2017
|
Other versions |
|
Summary report(s) |
CSR synopsis PM0028 EUdraCT |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.